NCT06139302View on ClinicalTrials.gov

A Study to Test How Different Doses of BI 1015550 Are Taken up in the Body of Healthy Japanese Men

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

February 7, 2024

Study Completion Date

February 13, 2024

Conditions
Healthy
Interventions
DRUG

BI 1015550

BI 1015550

Trial Locations (1)

130-0004

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06139302 - A Study to Test How Different Doses of BI 1015550 Are Taken up in the Body of Healthy Japanese Men | Biotech Hunter | Biotech Hunter